ClinicalTrials.gg
Drug

Reboxetine clinical trials

Also written Edronax®.

studies test it
31
open now
3
in phase 3
7
first study started
2003

How each study uses Reboxetine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Reboxetine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Reboxetine
11
[S,S]-Reboxetine
11
AXS-12 (reboxetine)
3

Brand

Edronax®
4

Studies by the year they started

31 studies that test it; most in 2006 (7)

Studies that test Reboxetine, by start year
YearStudies
20031
20041
20052
20067
20076
20081
20092
20121
20151
20193
20201
20212
20221
20231
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
14
Phase 3
7
Phase 4
2
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 14

Pfizer (13) · Axsome Therapeutics, Inc. (3) · University of Zurich (2) · University of Haifa (2) · Universitätsklinikum Hamburg-Eppendorf (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · University of Oxford (1) · Guiyang Medical University (1)

Often tested with

Tested in the same studies.

Methylphenidate (4) · Sertraline (4) · Citalopram (3) · Rivastigmine (2) · Venlafaxine (2) · Pregabalin (2) · Nicotine Chewing Gum (1) · Nicotine (1)

Studies

Open first, then newest update. How each study uses Reboxetine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 31

See all 31 studies that test Reboxetine →

As the comparator · 2 — what is tested is compared with Reboxetine

Codes

What other systems call Reboxetine · ClinicalTrials.gg INT006767

  • MeSH (NLM) D000077593ReboxetineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 947S0YZ36IREBOXETINEConfirmed FDA, NLM, Wikidata
  • RxNorm 60842One source FDA
  • Wikidata Q418970(RS,RS)-reboxetineConfirmed FDA, NLM, Wikidata
  • Wikidata Q72506458(R,R)-reboxetineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C72838ReboxetineOne source FDA
  • DrugBank DB00234One source Wikidata

Also registered as reboxetine mesylate (UNII L94J81YNNY · RxNorm 60841).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.